GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (NYSE:GSK) » Definitions » ROE % Adjusted to Book Value

GSK (GSK) ROE % Adjusted to Book Value : 2.40% (As of Dec. 2023)


View and export this data going back to 1987. Start your Free Trial

What is GSK ROE % Adjusted to Book Value?

GSK's ROE % for the quarter that ended in Dec. 2023 was 10.69%. GSK's PB Ratio for the quarter that ended in Dec. 2023 was 4.45. GSK's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 2.40%.


GSK ROE % Adjusted to Book Value Historical Data

The historical data trend for GSK's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK ROE % Adjusted to Book Value Chart

GSK Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.57 11.53 6.45 19.86 9.41

GSK Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.24 10.55 11.87 9.94 2.40

Competitive Comparison of GSK's ROE % Adjusted to Book Value

For the Drug Manufacturers - General subindustry, GSK's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GSK's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GSK's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where GSK's ROE % Adjusted to Book Value falls into.



GSK ROE % Adjusted to Book Value Calculation

GSK's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=41.86% / 4.45
=9.41%

GSK's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=10.69% / 4.45
=2.40%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GSK ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of GSK's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


GSK (GSK) Business Description

Industry
Address
980 Great West Road, Brentford, Middlesex, GBR, TW8 9GS
In the pharmaceutical industry, GSK ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.